ABVC
ABVC
NASDAQ · Biotechnology

Abvc Biopharma Inc

$1.06
+0.09 (+9.27%)
As of Apr 1, 3:41 PM ET ·
Financial Highlights (FY 2026)
Revenue
1.17M
Net Income
-11,243,139
Gross Margin
99.8%
Profit Margin
-962.1%
Rev Growth
+12.3%
D/E Ratio
1.46
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 99.8% 99.8% 67.1% 67.1%
Operating Margin -873.2% -785.9% 14.8% 13.2%
Profit Margin -962.1% -914.0% 12.9% 9.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.17M 1.04M 9.21M 8.21M
Gross Profit 1.17M 1.04M 6.18M 5.51M
Operating Income -10,214,643 -8,187,725 1.36M 1.08M
Net Income -11,243,139 -9,012,134 1.19M 806.0K
Gross Margin 99.8% 99.8% 67.1% 67.1%
Operating Margin -873.2% -785.9% 14.8% 13.2%
Profit Margin -962.1% -914.0% 12.9% 9.8%
Rev Growth +12.3% +12.3% -0.3% +20.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 10.64M 10.64M 16.13M 16.68M
Total Equity 7.29M 7.29M 18.59M 19.29M
D/E Ratio 1.46 1.46 0.87 0.86
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -9,709,254 -8,214,990 1.73M 1.63M
Free Cash Flow 900.3K 756.9K